Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.

Maryam Dadmanesh,Khodayar Ghorban,Hassan Aghajani,Reza Fadaei,Massimiliano Corsi

doi:10.1371/journal.pone.0204180

Maryam Dadmanesh, Khodayar Ghorban + Show 3 more

Open Access

https://doi.org/10.1371/journal.pone.0204180

Copy DOI

Abstract

Meteorin-like (Metrnl) is a newly discovered adipokine with favorable effect on insulin sensitivity. Previous studies have reported lower levels of Metrnl in obese patients. However, there is conflicting data regarding its circulating levels in type 2 diabetes mellitus (T2DM) and there is no data in patients with coronary artery disease (CAD). The aim of the present study was to evaluate the Metrnl serum level in patients with T2DM and CAD, and also to evaluate the serum levels of Metrnl with serum levels of adiponectin, IL-6 and TNF-α in patients. This study was conducted on 66 patients with CAD, 63 T2DM patients and 41 controls. The serum levels of Metrnl, adiponectin, IL-6 and TNF-α were measured using ELISA techniques. The serum levels of Metrnl were found to be lower in CAD (75.18 ± 28.48 pg/mL) and T2DM patients (73.89 ± 33.60 pg/mL) compared to the control group (95.33 ± 32.56 pg/mL) (p < 0.005 and p<0.003, respectively). Additionally, adiponectin decreased in CAD and T2DM patients as compared to the control group, while IL-6 and TNF-α were higher in CAD and T2DM patients. Metrnl showed independent association with the risk of CAD and T2DM presence. Furthermore, Metrnl illustrated a negative correlation with IL-6 and TNF-α in both CAD patients and also with BMI, insulin resistance, IL-6 and TNF-α in T2DM patients. Metrnl showed an association with CAD and T2DM presence and with components of their pathogenesis such as inflammation and insulin resistance. These results suggested a possible interaction between Metrnl and the pathogenesis of CAD and T2DM, however more studies are needed to prove this concept.

Highlights

The adipose tissue is an endocrine organ that secretes adipokines such as adiponectin, leptin, visfatin, resistin, vaspin, etc [1]
The results showed significantly increased Fasting blood glucose (FBG) and homeostatic model assessment of insulin resistance (HOMA-IR) in the type 2 diabetes mellitus (T2DM) group compared to the control and coronary artery disease (CAD) groups
TG was higher and high density lipoprotein-cholesterol (HDL)-C was lower in the T2DM group compared to the control group, while total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) showed no significant differences between both groups

Summary

Introduction

The adipose tissue is an endocrine organ that secretes adipokines such as adiponectin, leptin, visfatin, resistin, vaspin, etc [1]. Adipokines play important roles in whole body glucose and lipid metabolism as well as in inflammation [1]. CAD is a leading cause of death worldwide, and atherosclerosis is the main underlying mechanism of CAD [3]. Atherosclerosis is a progressive inflammatory disease and results to the accumulation of lipids in the arterial cell wall [3,4,5,6]. T2DM is a chronic metabolic disease and insulin resistance and β-cell dysfunction are the main underlying mechanisms [7,8]. It has been reported that obesity is associated with chronic inflammation and dysregulation of adipokine secretion and could be a possible link between obesity and increased risk of T2DM and CAD [9]

Objectives

Methods

Results

Conclusion